Ciphergen Biosystems, Inc.
Novel approach to detect cancer measures fragments of host response proteins
Published in Law and Health Weekly, July 30th, 2005
Ciphergen Diagnostics, a division of Ciphergen Biosystems, Inc., (CIPH) announced a publication in the International Journal of Cancer (115, 783-789) of findings suggesting that Surface Enhanced Laser Desorption/Ionization Time of Flight Mass Spectrometry (SELDI-TOF-MS) based immunologic and chromatographic assays can be used to detect and quantitatively assay for post-translationally modified forms of host response proteins, which may aid in the classification of cancer.
Although all cancer types generate a host response, this paper demonstrated that different cancers activate different subsets of host response proteins. By using Ciphergen's proprietary...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Hacettepe University, Ankara
N-acetylcysteine treatment has no prophylactic use - Istituto Nazionale Tumori Fond. G. Pascale
HIV-1 clade A virus-like particles elicit neutralizing antibodies - Medtronic, Inc.
Technology company purchases land for new headquarters, launches online resource - Myriad Genetics, Inc.
Biopharmaceutical company announces patent on amyloid lowering drugs - NMT Medical, Inc.
Medical technology company initiates patent foramen ovale closure study - National Prostate Cancer Coalition
ED drug amendment passage puts lives at risk, says prostate cancer organization - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
